Cycloserine Induced Psychosis, Insomnia and Suicidal Attempts in a Young Female Patient with Pre-Extensively Drug Resistant Tuberculosis
The World Health Organization classifies cycloserine as a group four second line anti tubercular drug for the treatment of drug resistant tuberculosis. Neuropsychiatric adverse drug reactions associated with cycloserine need more attention as they may compromise treatment success. Here, we report a...
Main Authors: | Priyanka Pravinbhai Hotha, Shubhima Grover, Rachna Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Research Center for Rational Use of Drugs (RCRUD)
2022-12-01
|
Series: | Journal of Pharmaceutical Care |
Subjects: | |
Online Access: | https://jpc.tums.ac.ir/index.php/jpc/article/view/535 |
Similar Items
-
Case report on cycloserine serum levels after treatment with oral terizidone and oral cycloserine
by: Lauren Rose, et al.
Published: (2024-01-01) -
Minimum inhibitory concentration of cycloserine against Mycobacterium tuberculosis using the MGIT 960 system and a proposed critical concentration
by: Xiao Wu, et al.
Published: (2022-08-01) -
Cycloserine-induced psychosis in patients with drug-resistant tuberculosis: a systematic review of case reports
by: Alonso Cotrina-Santome, et al.
Published: (2023-03-01) -
An Evaluation of the Effects of D-Cycloserine on Operant Learning and Response Recovery
by: Consuelo San Martín, et al.
Published: (2022-11-01) -
A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis
by: Wouter Deelder, et al.
Published: (2022-01-01)